Abstrakt: |
A recent study conducted by researchers from Federal University in Owerri, Nigeria, provides an overview of sickle cell disease (SCD), a hereditary blood disorder. SCD is characterized by the production of abnormal hemoglobin molecules, causing red blood cells to take on a crescent or sickle shape. This condition affects millions of people worldwide, particularly those of African, Mediterranean, Middle Eastern, and South Asian descent. The study explores the causes, symptoms, and available treatment options for SCD, emphasizing the importance of early diagnosis, symptom management, and improved quality of life for individuals with this chronic condition. Treatment options include pain management, hydration, blood transfusions, medication to increase fetal hemoglobin production, and bone marrow or stem cell transplants for severe cases. [Extracted from the article] |